Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 72 are a BUY (72%), 28 are a HOLD (28%).
Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 45.78% that have a potential upside of 50.82% achieved within 162 days.
Kalpit Patel’s has documented 200 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 23-Oct-2025.
Analyst best performing recommendations are on XFOR (X4 PHARMACEUTICALS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/2/2023. The price target of $16 was fulfilled within 5 days with a profit of $3.92 (32.45%) receiving and performance score of 64.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$10
$2.12 (26.90%)
$22
2 months 17 days ago
(11-Aug-2025)
1/13 (7.69%)
$2.78 (38.50%)
174
Hold
$13
$5.12 (64.97%)
$17
2 months 17 days ago
(11-Aug-2025)
0/8 (0%)
$5.78 (80.06%)
Buy
$48
2 months 18 days ago
(10-Aug-2025)
3/8 (37.5%)
$25.45 (112.86%)
192
Hold
$14
$6.12 (77.66%)
$17
5 months 27 days ago
(01-May-2025)
1/9 (11.11%)
$4.7 (50.54%)
12
Buy
$29
$21.12 (268.02%)
$30
5 months 27 days ago
(01-May-2025)
0/21 (0%)
$19.7 (211.83%)
Which stock is Kalpit Patel is most bullish on?
Which stock is Kalpit Patel is most reserved on?
What Year was the first public recommendation made by Kalpit Patel?